Chengdu Olymvax Biopharmaceuticals Inc
SSE:688319
Chengdu Olymvax Biopharmaceuticals Inc
SSE:688319
Price:
28.49
CNY
-2.9%
Market Closed
Market Cap:
¥11.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Chengdu Olymvax Biopharmaceuticals Inc
SSE:688319
|
CN |
Cash Flow Statement
Cash Flow Statement
Chengdu Olymvax Biopharmaceuticals Inc
Chengdu Olymvax Biopharmaceuticals Inc
Currency: CNY
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
|
| Cash Taxes Paid |
(12)
|
(13)
|
(14)
|
(15)
|
(17)
|
(19)
|
(23)
|
(32)
|
(35)
|
(37)
|
(43)
|
9
|
3
|
(26)
|
(14)
|
(35)
|
(41)
|
|
| Change in Working Capital |
(153)
|
(198)
|
(205)
|
(219)
|
(253)
|
(280)
|
(318)
|
(431)
|
(339)
|
(354)
|
(350)
|
(19)
|
(138)
|
(431)
|
(351)
|
(436)
|
(433)
|
|
| Cash from Operating Activities |
21
N/A
|
13
-39%
|
21
+68%
|
44
+103%
|
40
-8%
|
17
-57%
|
13
-27%
|
(98)
N/A
|
(25)
+75%
|
(15)
+41%
|
(11)
+23%
|
(37)
-231%
|
(41)
-11%
|
(10)
+76%
|
(12)
-26%
|
28
N/A
|
85
+200%
|
|
| Investing Cash Flow | ||||||||||||||||||
| Capital Expenditures |
(39)
|
(39)
|
(39)
|
(66)
|
(70)
|
(85)
|
(108)
|
(93)
|
(201)
|
(191)
|
(193)
|
(54)
|
(92)
|
(207)
|
(171)
|
(138)
|
(128)
|
|
| Other Items |
(10)
|
6
|
10
|
(258)
|
(186)
|
(226)
|
7
|
282
|
144
|
264
|
(24)
|
(95)
|
(112)
|
(17)
|
(57)
|
43
|
30
|
|
| Cash from Investing Activities |
(49)
N/A
|
(33)
+33%
|
(29)
+11%
|
(324)
-1 013%
|
(256)
+21%
|
(311)
-22%
|
(101)
+68%
|
189
N/A
|
(57)
N/A
|
73
N/A
|
(218)
N/A
|
(149)
+31%
|
(205)
-37%
|
(224)
-9%
|
(228)
-2%
|
(95)
+59%
|
(98)
-3%
|
|
| Financing Cash Flow | ||||||||||||||||||
| Net Issuance of Debt |
20
|
0
|
0
|
(2)
|
10
|
60
|
75
|
117
|
90
|
35
|
59
|
88
|
110
|
128
|
112
|
33
|
6
|
|
| Cash Paid for Dividends |
0
|
0
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(4)
|
(5)
|
(5)
|
(20)
|
(24)
|
(30)
|
(31)
|
(15)
|
(14)
|
|
| Other |
(2)
|
(3)
|
365
|
361
|
360
|
360
|
0
|
0
|
18
|
0
|
29
|
0
|
(2)
|
(2)
|
0
|
0
|
(2)
|
|
| Cash from Financing Activities |
18
N/A
|
17
-9%
|
389
+2 241%
|
359
-8%
|
369
+3%
|
419
+14%
|
66
-84%
|
111
+68%
|
103
-7%
|
48
-53%
|
84
+74%
|
56
-33%
|
72
+28%
|
96
+33%
|
66
-31%
|
15
-77%
|
(10)
N/A
|
|
| Change in Cash | ||||||||||||||||||
| Net Change in Cash |
(9)
N/A
|
(3)
+64%
|
382
N/A
|
78
-80%
|
153
+95%
|
125
-18%
|
(22)
N/A
|
202
N/A
|
22
-89%
|
106
+386%
|
(145)
N/A
|
(130)
+10%
|
(173)
-33%
|
(138)
+20%
|
(174)
-26%
|
(51)
+71%
|
(23)
+56%
|
|
| Free Cash Flow | ||||||||||||||||||
| Free Cash Flow |
(18)
N/A
|
(26)
-48%
|
(18)
+32%
|
(22)
-24%
|
(30)
-34%
|
(68)
-129%
|
(95)
-40%
|
(191)
-100%
|
(225)
-18%
|
(206)
+9%
|
(205)
+1%
|
(91)
+56%
|
(133)
-47%
|
(217)
-63%
|
(183)
+16%
|
(110)
+40%
|
(43)
+61%
|
|
Switch to:
Switch to:
See Also
Discover More
